ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer (Q43748039)

26 November 2017

title

ERCC1, RRM1 and BRCA1 mRNA expression levels and clinical outcome of advanced non-small cell lung cancer (English)

1 reference

26 November 2017

Chunxia Su

1

1 reference

26 November 2017

Songwen Zhou

2

1 reference

26 November 2017

Ling Zhang

3

1 reference

26 November 2017

Shengxiang Ren

4

1 reference

26 November 2017

Jianfang Xu

5

1 reference

26 November 2017

Jie Zhang

6

1 reference

26 November 2017

Meijun Lv

7

1 reference

26 November 2017

Jie Zhang

8

1 reference

26 November 2017

Caicun Zhou

9

1 reference

26 November 2017

publication date

14 May 2010

1 reference

26 November 2017

1 reference

26 November 2017

volume

28

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

1411-1417

1 reference

Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

BRCA1: a new genomic marker for non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Genetic variation in the DNA repair genes is predictive of outcome in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12032-010-9553-9

Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20467918

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20467918

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20467918

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S12032-010-9553-9

1 reference

Dimensions Publication ID

26 November 2017

1005827538

0 references

1 reference